Skip to main content
Top

Drug Safety

Issue 5/2007

Content (8 Articles)

Guidelines

Guidelines for Submitting Adverse Event Reports for Publication

William N. Kelly, Felix M. Arellano, Joanne Barnes, Ulf Bergman, Ralph I. Edwards, Alina M. Fernandez, Stephen B. Freedman, David I. Goldsmith, Kui A. Huang, Judith K. Jones, Rachel McLeay, Nicholas Moore, Rosie H. Stather, Thierry Trenque, William G. Troutman, Eugene van Puijenbroek, Frank Williams, Robert P. Wise

Commentary

Widespread Hyoscine Hydrobromide Toxicity Due to Contract Manufacturer Malpractice

John McEwen, Barry R. Thompson, Patrick M. Purcell, Larry F. Kelly, Adrian S. Krauss

Review Article

Drug-Related Problems in Hospitals

Anita Krähenbühl-Melcher, Raymond Schlienger, Markus Lampert, Manuel Haschke, Jürgen Drewe, Stephan Krähenbühl

Short Communication

Modifications of Low-Molecular Weight Heparin Use in a French University Hospital after Implementation of New Guidelines

Sophie Leclerc-Foucras, Haleh Bagheri, Kamran Samii, Jean-Louis Montastruc, Maryse Lapeyre-Mestre

Original Research Article

Safety of Zafirlukast

Beverley R. Twaites, Lynda V. Wilton, Saud A. W. Shakir

Original Research Article

Age- and Gender-Specific Incidence of Hospitalisation for Digoxin Intoxication

Adrianus L. H. J. Aarnoudse, Jeanne P. Dieleman, Bruno H. Ch. Stricker

Original Research Article

An Evaluation of the Cardiovascular Safety Profile of Duloxetine

Joachim Wernicke, Alberto Lledó, Joel Raskin, Daniel K. Kajdasz, Fujun Wang

Correspondence

Hospital-Based Adverse Drug Reaction Bulletin

Jimmy Jose, Padma G. M. Rao, Beena Jimmy